Other Transaction Agreement W911QY2090015
Award Date 7/7/20
Potential Completion Date 2/21/22
Potential Value $18M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Other
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, W911QY2190008, was issued by the Joint PEO Chemical and Biological Defense, a subcomponent of the U.S. Department of the Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 Other Transaction Agreement is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. Resilience Government Services, a technology-focused biomanufacturing company, has previously received federal...
- The U.S. Army Medical Command awarded a $38.6 million Other Transaction Order to Medical Technology Enterprise Consortium (MTEC) on June 23, 2020, to support the COVID-19 MTEC Project under Request for Project Proposals 20-09-COVID19, focusing on treatment and therapeutics development for COVID-19. MTEC, a nonprofit medical technology accelerator based in Summerville, South Carolina, serves as a collaborative platform that rapidly prototypes and fields innovative medical solutions for military...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $100.3 million other transaction agreement to Clinical Enterprise, Inc. to support the expansion of U.S. testing using coordination hubs 3 and 4. The prime contractor, Clinical Enterprise, Inc., will deliver coordination hub services for COVID-19 testing in Framingham, Massachusetts under the contract, which runs from May 2021 through December 2022. No set aside designation or subcontractors...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Eli Lilly and Company a $210 million firm fixed price delivery order for 100,000 doses of combination monoclonal antibody to support the national interest action code of Coronavirus COVID-19. Performance will take place in Indianapolis, Indiana under a November 2021 period of performance. No set aside designation or major subcontractors were indicated. This delivery order was issued against an...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $53.5 million other transaction agreement to The Johns Hopkins University under a COVID-19 convalescent plasma program. The prime contractor, Johns Hopkins University, will utilize the funds to support research and development efforts relating to convalescent plasma as part of the Department of Defense's medical countermeasures portfolio. Performance will take place in Baltimore, Maryland...
- Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., has been awarded a $162 million other transaction agreement by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to establish a COVID-19 prototype medical countermeasure manufacturing capability. The contract will support the development and production of medical countermeasures to combat COVID-19 and has a period of performance through August 2030. Nanotherapeutics will...
- The Defense Health Agency awarded a $25.7 million cost-plus-fixed-fee delivery order to Inbios International Inc., a minority-owned biotechnology company headquartered in Seattle, Washington. The contract, issued on June 15, 2020, supports COVID-19 diagnostic development efforts through FDA Emergency Use Authorization antigen detection optimization and fast-track serology assay advancement. The work will be performed in Seattle and is scheduled for completion by May 31, 2025. This delivery order...
- The Department of the Army, through its Sustainment Command, awarded a $848,556.96 delivery order against the Army Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense's Rapid COTS IDIQ vehicle. MJL Enterprises, LLC will perform work to modernize laboratories at Aberdeen Proving Ground in support of the Joint Program Executive Office's EMULATE COVID-19 program. Specifically, MJL Enterprises will provide firm fixed price labor and materials to upgrade facilities...
- The U.S. Army Medical Command awarded a $47.2 million Other Transaction Order to Medical Technology Enterprise Consortium (MTEC) on June 9, 2020, for prototype development under the COVID-19 NETCCN-TATRC project, with completion targeted for March 29, 2024. This award was issued without set-aside designation to MTEC, a nonprofit medical technology accelerator registered in the System for Award Management since December 2015. The work will be performed in Summerville, South Carolina, and...
- <p>The Department of the Army Acquisition Support Center Joint Program Executive Office for Chemical and Biological Defense (DOD - Army - USASC) awarded a $52 million firm fixed price definitive contract to Inbios International Inc. of Seattle, Washington to provide COVID-19 over-the-counter test kits. The contract runs from February 17, 2022 through September 9, 2022 to support the National Interest Action Code of Coronavirus COVID-19. No subcontractors were identified.</p>